Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / Developmental Immunotherapeutics in Cancer: Clinical Pharmacology Implications

Developmental Immunotherapeutics in Cancer: Clinical Pharmacology Implications

R. Donald Harvey, PharmD, FCCP, BCOP, Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine Director, Phase I Clinical Trials Section, Winship Cancer Institute
When Oct 15, 2013
from 04:00 PM to 05:00 PM
Where 00-002 Joseph S. Pagano Conference Room
Add event to calendar iCal

Oncology Grand Rounds/Lineberger Comprehensive Cancer Center
Hosted by Dr. Jon Serody